Literature DB >> 32533999

Viral-bacterial (co-)occurrence in the upper airways and the risk of childhood pneumonia in resource-limited settings.

James S Ngocho1, Linda Minja2, Christa E van der Gaast-de Jongh3, Janette C Rahamat-Langendoen4, Jeroen D Langereis3, Blandina T Mmbaga5, Marien I de Jonge3.   

Abstract

OBJECTIVE: To examine the association between bacterial-viral co-occurrence in the nasopharynx and the risk of community acquired pneumonia (CAP) in young children living in resource-limited settings.
METHODS: A case-control study was conducted between January and December 2017 in Moshi, Tanzania. Children 2-59 months with CAP and healthy controls were enrolled. RSV and Influenza A/B were detected with a standardized polymerase chain reaction (PCR) method, and a simplified real-time quantitative PCR method, without sample pre-processing, was developed to detect bacterial pathogens in nasopharyngeal samples.
RESULTS: A total of 109 CAP patients and 324 healthy controls were enrolled. Co-detection of H. influenzae and S. pneumoniae in nasopharyngeal swabs was linked with higher odds of CAP (aOR=3.2, 95% CI=1.1-9.5). The majority of the H. influenzae isolated in cases and controls (95.8%) were non-typeable. Of the viruses examined, respiratory syncytial virus (RSV) was most common (n = 31, 7.2%) in cases and controls. Children with RSV had 8.4 times higher odds to develop pneumonia than healthy children (aOR=8.4, 95%CI= 3.2 - 22.1).
CONCLUSIONS: Co-occurence of H. influenzae and S. pneumoniae in the nasopharynx was strongly associated with CAP. The high prevalence of non-typeable H. influenzae might be a sign of replacement as a consequence of Haemophilus influenzae type b vaccination.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Bacterial and viral colonization; Children under five years of age; Community-acquired pneumonia; Tanzania

Mesh:

Year:  2020        PMID: 32533999      PMCID: PMC7392802          DOI: 10.1016/j.jinf.2020.06.013

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  38 in total

1.  Evaluation of a triplex PCR assay to discriminate Staphylococcus aureus from coagulase-negative Staphylococci and determine methicillin resistance from blood cultures.

Authors:  N Maes; J Magdalena; S Rottiers; Y De Gheldre; M J Struelens
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Neuraminidase expressed by Streptococcus pneumoniae desialylates the lipopolysaccharide of Neisseria meningitidis and Haemophilus influenzae: a paradigm for interbacterial competition among pathogens of the human respiratory tract.

Authors:  Elizabeth A Shakhnovich; Samantha J King; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

Review 3.  10-valent pneumococcal nontypeable Haemophilus influenzae PD conjugate vaccine: Synflorix.

Authors:  Roman Prymula; Lode Schuerman
Journal:  Expert Rev Vaccines       Date:  2009-11       Impact factor: 5.217

4.  Epidemiology and etiology of childhood pneumonia.

Authors:  Igor Rudan; Cynthia Boschi-Pinto; Zrinka Biloglav; Kim Mulholland; Harry Campbell
Journal:  Bull World Health Organ       Date:  2008-05       Impact factor: 9.408

Review 5.  Moraxella catarrhalis, a human respiratory tract pathogen.

Authors:  Timothy F Murphy; G Iyer Parameswaran
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

6.  Carriage of penicillin-non-susceptible pneumococci among children in northern Tanzania in the 13-valent pneumococcal vaccine era.

Authors:  Matilda Emgård; Sia E Msuya; Balthazar M Nyombi; Dominic Mosha; Lucia Gonzales-Siles; Rickard Nordén; Shadi Geravandi; Victor Mosha; Josefine Blomqvist; Sofie Franzén; Fredrika Sahlgren; Rune Andersson; Susann Skovbjerg
Journal:  Int J Infect Dis       Date:  2019-01-24       Impact factor: 3.623

7.  Associations Between Viral and Bacterial Potential Pathogens in the Nasopharynx of Children With and Without Respiratory Symptoms.

Authors:  Chrysanthi L Skevaki; Paraskevi Tsialta; Aikaterini I Trochoutsou; Ioanna Logotheti; Heidi Makrinioti; Styliani Taka; Evangelia Lebessi; Irene Paraskakis; Nikolaos G Papadopoulos; Maria N Tsolia
Journal:  Pediatr Infect Dis J       Date:  2015-12       Impact factor: 2.129

8.  Molecular surveillance of true nontypeable Haemophilus influenzae: an evaluation of PCR screening assays.

Authors:  Michael J Binks; Beth Temple; Lea-Ann Kirkham; Selma P Wiertsema; Eileen M Dunne; Peter C Richmond; Robyn L Marsh; Amanda J Leach; Heidi C Smith-Vaughan
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

9.  Reduced middle ear infection with non-typeable Haemophilus influenzae, but not Streptococcus pneumoniae, after transition to 10-valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine.

Authors:  Amanda Jane Leach; Christine Wigger; Kim Hare; Vanya Hampton; Jemima Beissbarth; Ross Andrews; Mark Chatfield; Heidi Smith-Vaughan; Peter Stanley Morris
Journal:  BMC Pediatr       Date:  2015-10-19       Impact factor: 2.125

10.  Factors associated with the uptake of newly introduced childhood vaccinations in Ethiopia: the cases of rotavirus and pneumococcal conjugate vaccines.

Authors:  Abrham Wondimu; Qi Cao; Jan C Wilschut; Maarten J Postma
Journal:  BMC Public Health       Date:  2019-12-10       Impact factor: 3.295

View more
  2 in total

1.  Nasopharyngeal colonisation dynamics of bacterial pathogens in patients with fever in rural Burkina Faso: an observational study.

Authors:  Liesbeth Martens; Bérenger Kaboré; Annelies Post; Christa E van der Gaast-de Jongh; Jeroen D Langereis; Halidou Tinto; Jan Jacobs; André J van der Ven; Quirijn de Mast; Marien I de Jonge
Journal:  BMC Infect Dis       Date:  2022-01-04       Impact factor: 3.090

2.  High bacterial and viral load in the upper respiratory tract of children in the Democratic Republic of the Congo.

Authors:  Archippe Muhandule Birindwa; Lucia Gonzales-Siles; Rickard Nordén; Shadi Geravandi; Jeanière Tumusifu Manegabe; Lambert Morisho; Stay Saili Mushobekwa; Rune Andersson; Susann Skovbjerg
Journal:  PLoS One       Date:  2020-10-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.